At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation - Pilot Trial
In Brief
A clinical study evaluating Rate Control, Ablation Therapy, and 3 other interventions for Atrial Fibrillation and Arrhythmia. Completed, enrolled 60 participants across 10 sites.
Detailed Summary
The CABANA pilot study is designed to test the hypothesis that the treatment strategy of percutaneous left atrial catheter ablation for the purpose of the elimination of atrial fibrillation (AF) is superior to current state-of-the-art therapy with either rate control or anti-arrhythmic drugs for reducing AF recurrences at 1 year follow-up.
Study Details
Timeline
Interventions
Metoprolol 50-100mg
Atenolol 50-100mg,
Propranolol 40-80mg
Acebutolol 200mg
Carvedilol 6.25mg
Diltiazem 180-240mg
Verapamil 180-240mg
Digoxin 0.125mg
Propafenone 450mg
Flecainide 200mg
Sotalol 240mg
Dofetilide 500mcg
Amiodarone 200mg
Quinidine 600-900mg